Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 29 Magnetic Resonance Spectroscopy 20 Biopsy 19 Cyclophosphamide 8 venetoclax 5 Bevacizumab 5 Vincristine 4 Taxes 4 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Nivolumab 4 Etoposide 4 Cetuximab 4 Azacitidine 4 fludarabine phosphate 3 fludarabine 3 decitabine and cedazuridine drug combination 3 X-Rays 3 Radiosurgery 3 Radiation 3 Prednisone 3 Doxorubicin 3 zanubrutinib 2 trastuzumab deruxtecan 2 prednylidene 2 olaparib 2 iadademstat 2 deltacortene 2 Tacrolimus 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × HM781-36B × 90 days × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡